课题基金 / 基金详情

EDUCATIONAL RESOURCE FOR TUMOR HETEROGENEITY

EDUCATIONAL RESOURCE FOR TUMOR HETEROGENEITY
肿瘤异质性教育资源
批准号:
2458114
负责人:
ROGER S. DAY
金额:
$19.99万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1999-07-31

项目摘要

项目成果

ROGER S. DAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Oncologists think about the natural history of tumors in interaction with treatments using informal reasoning that can lead to incorrect conclusions. The biological assumptions and hypotheses that oncologists use often have counterintuitive consequences. A substantial body of research literature exists describing the calculation of the whole-person consequences of hypotheses at the cellular level, but this knowledge has been largely inaccessible to oncologists, and has generally failed to affect their thinking or improve their intuition. As a result, the ability of oncologists to make optimal use of currently available anticancer agents has been impeded. Consequently, we propose the development of a resource package consisting of biomathematical modelling software, tutorials, and documentation. The goal is to train current and future research oncologists in the theory of tumor cell population kinetics as applied to cancer treatment, leading to improved selection of new hypotheses to test in clinical and laboratory studies, as well as improved interpretation of results. Objective 1: For training medical students, a short introductory module on tumor heterogeneity will be developed for use in classroom training. The module will consist of lecture materials, printed study materials and simulation-based exercises. Objective 2: For training oncology fellows, a suite of self-directed study modules will be developed. The goal is a set of tutorial lessons developed with integral contributions from outstanding researchers in clinical oncology. Tutorials will demonstrate key lessons in tumor cell kinetics, while teaching the use of the program for incorporating specific biological phenomena (metastasis, differentiation, nonlinear dose-response and drug interactions, pleiotropic resistance, multiple resistance mechanisms, angiogenesis, treatment-induced mutation, toxicity, etc.). Objective 3: For active cancer researchers, a flexible hypothesis-neutral modeling resource will be developed. Building on the tutorials developed for training of fellows, we will provide a software suite which will allow researchers facing a particular treatment question to describe, in a most natural way, their own conceptions of the disease natural history, and to train themselves, developing insights into the consequences of their hypotheses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MARKOV PROCESSES AND CLINICAL TRIAL DESIGN
  • 批准号:
    8364221
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2011
  • 负责人:
    ROGER S. DAY
  • 依托单位:
MARKOV PROCESSES AND CLINICAL TRIAL DESIGN
  • 批准号:
    8171795
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2010
  • 负责人:
    ROGER S. DAY
  • 依托单位:
MARKOV PROCESSES AND CLINICAL TRIAL DESIGN
  • 批准号:
    7956320
  • 项目类别:
  • 资助金额:
    $0.08万
  • 财政年份:
    2009
  • 负责人:
    ROGER S. DAY
  • 依托单位:
AN ADAPTIVE BAYESIAN APPROACH TO JOINTLY MODELING RESPONSE AND TOXICITY IN PHAS
  • 批准号:
    7601385
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2007
  • 负责人:
    ROGER S. DAY
  • 依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
  • 批准号:
    81200692
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    陈凌
  • 依托单位: